错误部

The Lancet Pub Date : 2025-07-10 DOI:10.1016/s0140-6736(25)01396-0

{"title":"错误部","authors":"","doi":"10.1016/s0140-6736(25)01396-0","DOIUrl":null,"url":null,"abstract":"Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A. Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 2025; 405: 1014–26—In this paper, the grey circle indicating an area of blockade of CGRP receptor in figure 2 has been adjusted. This correction has been made to the online version as of July 10, 2025.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Department of Error\",\"authors\":\"\",\"doi\":\"10.1016/s0140-6736(25)01396-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A. Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 2025; 405: 1014–26—In this paper, the grey circle indicating an area of blockade of CGRP receptor in figure 2 has been adjusted. This correction has been made to the online version as of July 10, 2025.\",\"PeriodicalId\":22898,\"journal\":{\"name\":\"The Lancet\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0140-6736(25)01396-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0140-6736(25)01396-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

刘建军，张建军，张建军，等。降钙素基因相关肽靶向治疗偏头痛的研究进展。《柳叶刀》2025年;405: 1014 - 26本文对图2中表示CGRP受体阻断区域的灰色圆圈进行了调整。此更正已于2025年7月10日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Department of Error

Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A. Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 2025; 405: 1014–26—In this paper, the grey circle indicating an area of blockade of CGRP receptor in figure 2 has been adjusted. This correction has been made to the online version as of July 10, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet

自引率

0.00%

发文量